GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BDH Industries Ltd (BOM:524828) » Definitions » COGS-to-Revenue

BDH Industries (BOM:524828) COGS-to-Revenue : 0.74 (As of Mar. 2024)


View and export this data going back to 1995. Start your Free Trial

What is BDH Industries COGS-to-Revenue?

BDH Industries's Cost of Goods Sold for the three months ended in Mar. 2024 was ₹201.4 Mil. Its Revenue for the three months ended in Mar. 2024 was ₹271.1 Mil.

BDH Industries's COGS to Revenue for the three months ended in Mar. 2024 was 0.74.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. BDH Industries's Gross Margin % for the three months ended in Mar. 2024 was 25.71%.


BDH Industries COGS-to-Revenue Historical Data

The historical data trend for BDH Industries's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BDH Industries COGS-to-Revenue Chart

BDH Industries Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.62 0.66 0.71 0.67 0.70

BDH Industries Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.73 0.72 0.65 0.68 0.74

BDH Industries COGS-to-Revenue Calculation

BDH Industries's COGS to Revenue for the fiscal year that ended in Mar. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=602.755 / 858.31
=0.70

BDH Industries's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=201.393 / 271.082
=0.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BDH Industries  (BOM:524828) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

BDH Industries's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 201.393 / 271.082
=25.71 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


BDH Industries COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of BDH Industries's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


BDH Industries (BOM:524828) Business Description

Traded in Other Exchanges
N/A
Address
Nair Baug, Akurli Road, Kandivli (East), Mumbai, MH, IND, 400101
BDH Industries Ltd is an India based pharmaceutical company. It is engaged in the manufacturing of therapeutic formulations including various pharmaceuticals. The Company has one reportable segment which is pharmaceuticals. The company's product portfolio encompasses therapeutic categories including antifungal, antibiotics, anticancer, antidiabetic, antidepressant, antiulcerant, antimalarials, anti-inflammatory, analgesic, antispasmodic, anti-tuberculosis, cardiovascular, dermatological, psychotropic, and others. It manufactures Sildenafil Citrate Tablets, Bulk Drugs and Others.

BDH Industries (BOM:524828) Headlines

No Headlines